Amendment No. 1 to Master Services Agreement, effective February 12, 2025, between Cingulate Therapeutics LLC and Societal CDMO, Inc. (DBA Bend Bioscience)
Contract Categories:
Business Operations
- Services Agreements
EX-10.3 3 ex10-3.htm
Exhibit 10.3